Chem21-programma

Together with 5 other pharmaceutical companies and 13 academic research institutions and SMEs in Europe, Janssen joined forces with a view to developing sustainable production methods for medicines.
In 2013 the active pharmaceutical ingredient buprenorfine was granted an EARTHWARDSTM certificate. This is the seventh pharmaceutical product to receive this recognition. Buprenorfine is a narcotic painkiller which is used both for acute and chronic pain control and for the treatment of narcotic drug addiction.

The product was given the certification because it met the strict criteria on green production: less raw materials, less water, less waste and an innovative production process.